IK-15800

N/A

Report date: 2025/01/26 18:48:08
NME

Base Information

Drug NameIK-15800
Drug Alias Nameprotein kinase inhibitor (Interk Peptide)IK-15800
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases inhibitors
TargetsProtein kinases
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInterK Peptide Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInterK Peptide Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A